This paper presents a methodological review of models for predicting blood glucose (BG)
concentration, risks and BG events. The surveyed models are classified into three …

The level of glycaemic control necessary to achieve optimal short‐term and long‐term
outcomes in subjects with type 1 diabetes mellitus (T1DM) typically requires intensified …

Abstract Machine learning has become a popular tool for learning models of complex
dynamics from biomedical data. In Type 1 Diabetes (T1D) management, these models are …

Background An artificial pancreas (AP) that can be worn at home from dinner to waking up in
the morning might be safe and efficient for first routine use in patients with type 1 diabetes …

Integrated closed-loop control (CLC), combining continuous glucose monitoring (CGM) with
insulin pump (continuous subcutaneous insulin infusion [CSII]), known as artificial pancreas …

Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and
control algorithms have resulted in an acceleration of progress in the development of …

Despite the continuous efforts devoted to AP development in the last decades, an artificial
pancreas (AP) system is not yet available on the market. One of the major issues involves …

Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

Background: The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic
improvements in large randomized controlled and real-world trials. Use of this system is …

Pursuit of a closed-loop artificial pancreas that automatically controls the blood glucose of
individuals with type 1 diabetes has intensified during the past 6years. Here we discuss the …